Effects of duloxetine on pain and walking distance in neuropathic pain models via modulation of the spinal monoamine system

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-2149|22|2|355-369

ISSN： 1090-3801

Source： EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol.22, Iss.2, 2018-02, pp. : 355-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK

By Beard S. M.   McCrink L.   Le T. K.   Garcia-Cebrian A.   Monz B.   Malik R. A.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 385-399

Informa Healthcare

Access to resources Recommend Favorite

Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients

By  

Current Drug Safety, Vol. 4, Iss. 1, 2009-01 ,pp. : 22-29

Bentham Science Publishers

Access to resources Recommend Favorite

Pregabalin for the management of neuropathic pain in spinal cord injury

By Dalal Kevin L   Felix Elizabeth R   Cardenas Diana D  

Pain Management, Vol. 3, Iss. 5, 2013-09 ,pp. : 359-367

Future Medicine

Access to resources Recommend Favorite

Neuropathic Pain

By  

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 6, Iss. 3, 2003-07 ,pp. : 193-194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neural Markers of Neuropathic Pain Associated with Maladaptive Plasticity in Spinal Cord Injury

By  

PAIN PRACTICE, Vol. 15, Iss. 4, 2015-04 ,pp. : 371-377

John Wiley & Sons Inc

Access to resources Recommend Favorite